Assembly Biosciences, Inc. Accounts Payable
Assembly Biosciences, Inc. (ASMB) had Accounts Payable of $1.18 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $1.18M.
- 2026-03-31: Accounts Payable, Current $1.13M.
- 2025-12-31: Accounts Payable, Current $1.17M.
- 2025-09-30: Accounts Payable, Current $1.68M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.13M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.17M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.68M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $743.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $875.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $585.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.33M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $801.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $727.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $461.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $758.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $904.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.49M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.94M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.45M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.41M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.66M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.63M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.87M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.56M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.60M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.61M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.64M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.10M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.73M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.71M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $3.69M 10-K · filed 2020-03-04 |
| 2014-06-30 | $1.42M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.44M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $2.61M 10-Q · filed 2014-08-14 |
| 2013-09-30 | $2.28M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.13M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.53M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.85M 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.84M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $3.16M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $3.14M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $2.34M 10-K · filed 2013-03-18 |
| 2011-06-30 | $621.73K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $312.90K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |